Focused rooms.
Important conversations.
KOL Network creates faculty-driven scientific meetings designed around areas where the science is moving quickly and meaningful expert discussion matters.
A faculty-driven hematology summit bringing established leaders, rising stars and fellows into the same scientific conversation. The full program, faculty and session detail remain available.
Drug Resistance
A cross-disease meeting focused on the mechanisms driving resistance, relapse and therapeutic evolution across hematologic malignancies.
Heme Summit
The second edition of the flagship summit, returning to Denver — established leaders, rising stars and fellows in the same scientific conversation.
New summits are in development as the KOL Network platform grows. Focus areas and dates announced to the network first.
Cellular therapy, bispecifics, novel targets, sequencing and the changing treatment landscape.
Disease-Specific · Dates to be announced
Aggressive and indolent lymphomas, cellular therapy, bispecifics, ADCs and targeted approaches.
Disease-Specific · Dates to be announced
BTK, BCL2, sequencing, resistance and next-generation targeted therapy.
Disease-Specific · Dates to be announced
Myelofibrosis, polycythemia vera, essential thrombocythemia and emerging therapeutic strategies.
Disease-Specific · Dates to be announced
A cross-disease meeting focused on the rapidly evolving immune and cellular therapy landscape.
Disease-Specific · Dates to be announced
A cross-disease scientific meeting highlighting the research, leadership and perspectives of women shaping oncology and hematology.
Disease-Specific · Dates to be announced
The network
in numbers.
Summits in the series
Faculty seats
Leading institutions
Cities · Denver & Chicago
Interested in a future summit?
New scientific properties are announced to the network first. Get in touch to be notified as dates, faculty and locations are confirmed.